Gangloff Scott A. (CIK 1663253) reported 5 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2025-12-09). Recent activity: Sell AKRO (5,088 shares), Sell AKRO (21,263 shares), Buy AKRO (2,600 shares), Buy AKRO (299 shares), Sell AKRO (848 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Technology Officer | Sell | 5,088 | $0 |
| 2025-12-09 | Akero Therapeutics, Inc. (AKRO) | Chief Technology Officer | Sell | 21,263 | $0 |
| 2025-08-19 | Akero Therapeutics, Inc. (AKRO) | Chief Technology Officer | Buy | 2,600 | $51,012 |
| 2025-07-02 | Akero Therapeutics, Inc. (AKRO) | Chief Technology Officer | Buy | 299 | $7,137 |
| 2025-06-20 | Akero Therapeutics, Inc. (AKRO) | Chief Technology Officer | Sell | 848 | $46,504 |
Source: SEC Form 4 filings · as of 2025-12-09